Premedication and Infusion Reactions With Infliximab: Results From a Pediatric Inflammatory Bowel Disease Consortium
Douglas A Jacobstein(Children's Hospital of Philadelphia), Robert N. Baldassano(Children's Hospital of Philadelphia), Barbara S. Kirschner(Comer Children's Hospital), Stanley A. Cohen(Troy Gastroenterology), Harland S. Winter(Harvard University), Benjamin D. Gold(Emory University), Melvin B. Heyman(University of California, San Francisco), Jonathan E. Markowitz, George D. Ferry(Baylor College of Medicine)
Cited by 92
Related Papers
Human gut microbiome viewed across age and geography
|Nature|2012|7.9k
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k